At a Glance
Anthos Capital is a venture capital firm based in Menlo Park, CA founded in 2018. The firm focuses on Pre-Seed, Seed, Series A, Series B+ investments across sectors including Aerospace & Defense, Digital Health, Other, Consumer, Fintech. The firm manages $1.7B in assets under management. Notable portfolio companies include BioNTech, Alnylam, Veracyte and 10x Genomics. Invests in growth-stage healthcare and technology companies with focus on transformative healthcare solutions.
“Invests in growth-stage healthcare and technology companies with focus on transformative healthcare solutions.”
Anthos Capital primarily invests at the Pre-Seed, Seed, Series A, Series B+ stages. This means they focus on companies that are at the earliest idea or prototype phase.
Anthos Capital is headquartered in Menlo Park, CA. Many of their portfolio companies are also based in this region, though they invest across geographies.
Anthos Capital focuses on investments in Aerospace & Defense, Digital Health, Other, Consumer, Fintech. Their portfolio reflects deep expertise and networks within these sectors.
Anthos Capital's typical investment check size ranges from $500K to $10M. Actual amounts may vary based on the stage, sector, and specific opportunity.
Anthos Capital manages approximately $1.7B in assets under management (AUM) across their funds.
